Back to search
Complicated Intra-abdominal Infections (cIAI)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Complicated Intra-abdominal Infections (cIAI) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Complicated Intra-abdominal Infections (cIAI) trials you may qualify forA Phase 2 trial to assess safety, tolerability, and pharmacokinetics of eravacycline in pediatric patients aged 8 to \<18 years with cIAI.
The study will evaluate the efficacy and safety of Meropenem and Pralurbactam versus Best Available Therapy in the treatment of Carbapenem-Resistant Enterobacte…
The primary purpose of this study is to understand the pharmacokinetics (PK) of single and multiple doses of cefiderocol in children from birth to less than 3 m…
The primary objectives of this study are: * To assess the safety and tolerability of cefiderocol after single-dose administration in hospitalized paediatric pa…